Trench Fever Treatment Market Outlook:
Trench Fever Treatment Market size was valued at USD 151.6 million in 2024 and is projected to reach approximately USD 343.6 million by the end of 2037, rising at a CAGR of 6.5% during the forecast period, i.e., 2025–2037. In 2025, the industry size of trench fever treatment is assessed at USD 159.9 million.
The huge proportion of trench fever cases occurs particularly in unhoused populations in various urban settings. According to the Centers for Disease Control and Prevention study, conducted in San Francisco, 31% of the surveyed unhoused people had body lice infestations. It further stated that 16.2% of them were carrying trench fever causing pathogen, named Bartonella quintana. These figures instill the necessity of conducting testing across prominent urban centers with a large pool of the homeless population across the world.
The Bureau of Labor Statistics tracked the antibiotic PPI and showed 2.1-3% year-over-year growth in the last year, showcasing a moderate inflation in the manufacturing costs. The government-funded initiatives help in keeping surveillance for trench fever and providing adequate diagnostic and treatment. In 2022, the CDC allocated USD 2.1 million for the urban louse-borne pathogen. Additionally, the antibiotic APIs are mainly exported from China and India to various parts of North America and Europe. Exports of diagnostic kits come under repurposed pharmaceutical formulations.
